Stay updated on CTII-nCoV Vaccine: Phase II Clinical Trial
Sign up to get notified when there's something new on the CTII-nCoV Vaccine: Phase II Clinical Trial page.

Latest updates to the CTII-nCoV Vaccine: Phase II Clinical Trial page
- Check5 days agoChange DetectedThe page now displays the study record for a Phase II trial evaluating the Ad5-nCoV COVID-19 vaccine, including its design, participant criteria, arms, outcome measures, and study history.SummaryDifference49%

- Check13 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedA site-wide notice appears announcing NIH website updates and explaining that some content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check26 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check33 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record content. The header and footer remain visible, indicating a site-wide access restriction rather than a content update to the study information.SummaryDifference18%

Stay in the know with updates to CTII-nCoV Vaccine: Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTII-nCoV Vaccine: Phase II Clinical Trial page.